TrialBritish journal of haematology2017

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.

Jeffrey A Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.